Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 11 (RPL32P11) is a human processed pseudogene related to the RPL32 gene, which encodes the ribosomal protein L32, a structural component of the large 60S ribosomal subunit[1][3][6]. Pseudogenes like RPL32P11 result from the duplication or retrotransposition of functional genes but have lost the ability to encode a protein due to accumulated mutations—such as lack of introns and/or early stop codons[2][1]. RPL32P11 does not produce a functional ribosomal protein, is not known to regulate other genes, and lacks a role in disease or therapy. It is one of several RPL32-related pseudogenes found throughout the human genome[1][2]. No drugs, biomarkers, or mechanisms of drug action are associated with RPL32P11.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 11 (RPL32P11).